» Articles » PMID: 3353622

Prognostic Factors for Local Recurrence and Survival in Patients with Localized Extremity Soft-tissue Sarcoma

Overview
Specialty Oncology
Date 1988 Jan 1
PMID 3353622
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The charts of 423 patients with localized extremity soft-tissue sarcoma treated at our institution over a 10-year period (1968-1978) were reviewed. Data were subjected to both univariate and multivariate analysis, with independent variables in the multivariate analysis appearing in capital letters. Factors associated with an increased risk of local recurrence included the following: AGE greater than 53; PRESENTATION WITH RECURRENT DISEASE; HIGH TUMOR GRADE; positive regional nodes; TREATMENT BY LIMB-SPARING SURGERY (LSS); invasion of vital structures (LSS only); INADEQUATE MARGINS; and biopsy with delayed definitive resection. Survival was adversely affected by the following: AGE greater than 53; PAINFUL MASS; PROXIMAL SITE; SIZE greater than or equal to 10 cm; HIGH TUMOR GRADE; POSITIVE NODES; invasion of vital structures; TREATMENT BY AMPUTATION; INADEQUATE MARGINS; and local recurrence after treatment at our institution. Significant variations in both local recurrence and survival according to histopathology were also observed, with EMBRYONAL RHABDOMYOSARCOMA, ANGIOSARCOMA, and MALIGNANT PERIPHERAL NERVE TUMORS emerging as independent predictors of local recurrence. Using the Cox models for local recurrence and survival, patients were stratified into high-, intermediate-, and low-risk categories based on the presence or absence of each variable. Risk factor analysis should be part of the overall evaluation of each patient with extremity sarcoma.

Citing Articles

Outcome of Soft Tissue Popliteal Sarcomas: 15 Years of Experience.

Tepedelenlioglu H, Tolunay T, Orhan O, Arikan S, Akgun E, Togral G Indian J Orthop. 2024; 59(1):34-39.

PMID: 39735885 PMC: 11680513. DOI: 10.1007/s43465-024-01263-8.


Evaluation of the factors affecting survival and local recurrence in thigh soft tissue sarcomas.

Yildirim S, Ciftdemir M, Ustabasioglu F, Ustun F, Usta U Jt Dis Relat Surg. 2023; 35(1):130-137.

PMID: 38108174 PMC: 10746889. DOI: 10.52312/jdrs.2023.1289.


Induction of VX2 para-renal carcinoma in rabbits: generation of animal model for loco-regional treatments of solid tumors.

Bimonte S, Leongito M, Piccirillo M, Tamma M, Vallifuoco M, Bracco A Infect Agent Cancer. 2016; 11:62.

PMID: 27980609 PMC: 5134289. DOI: 10.1186/s13027-016-0103-8.


Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas.

Nathenson M, Sausville E Cancer Chemother Pharmacol. 2016; 78(5):895-919.

PMID: 27206640 PMC: 7577379. DOI: 10.1007/s00280-016-3055-1.


Evidence and clinical outcomes of adult soft tissue sarcomas of the extremities treated with adjuvant high-dose-rate brachytherapy - a literature review.

Pellizzon A J Contemp Brachytherapy. 2014; 6(3):318-22.

PMID: 25337137 PMC: 4200188. DOI: 10.5114/jcb.2014.45758.